| Journal of Medical Cases, ISSN 1923-4155 print, 1923-4163 online, Open Access |
| Article copyright, the authors; Journal compilation copyright, J Med Cases and Elmer Press Inc |
| Journal website https://jmc.elmerpub.com/ |
Case Report
Volume 15, Number 12, December 2024, pages 367-370
New Onset of Type 1 Diabetes Mellitus Post-COVID-19 Vaccine
Table
| Assessment | Results | Reference ranges |
|---|---|---|
| TSH: thyroid-stimulating hormone; GAD: glutamic acid decarboxylase; ZnT8: zinc transporter 8. | ||
| Fasting glucose, mmol/L | 15.74 | 4.07 - 5.83 |
| Hemoglobin A1c, % | 10.8 | 4 - 6 |
| Fasting C-peptide, nmol/L | < 0.5 | 0.16 - 1.68 |
| Urea, mmol/L | 3.6 | 2.5 - 6.4 |
| Creatinine, mmol/L | 52 | 53 - 115 |
| Sodium, mmol/L | 139 | 136 - 145 |
| Potassium, mmol/L | 4.3 | 3.5 - 5.1 |
| TSH, mIU/L | 3.336 | 0.25 - 5 |
| Free T4, pmol/L | 15.2 | 11.5 - 22.7 |
| Anti-GAD antibody, IU/mL | 330.7 | < 10 |
| Anti-islet cells antibody, U/mL | 27 | < 28 |
| Anti-ZnT8 antibody, U/mL | 2 | < 15 |
| Insulin autoantibody, U/mL | < 0.4 | < 0.4 |